BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11895912)

  • 1. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
    Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
    Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to childhood leukemia].
    Zhu R; Xia Z
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):635-8. PubMed ID: 15612500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia.
    da Silva Silveira V; Canalle R; Scrideli CA; Queiroz RG; Bettiol H; Valera ET; Tone LG
    Leuk Res; 2009 Jul; 33(7):898-901. PubMed ID: 19162321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia.
    Canalle R; Burim RV; Tone LG; Takahashi CS
    Environ Mol Mutagen; 2004; 43(2):100-9. PubMed ID: 14991750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
    Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
    Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of genetic polymorphism of xenobiotic enzymes in acute leukemia.
    Eyada TK; El Ghonemy EG; El Ghoroury EA; El Bassyouni SO; El Masry MK
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):489-95. PubMed ID: 17581325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
    Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
    Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia.
    Krajinovic M; Richer C; Sinnett H; Labuda D; Sinnett D
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):557-62. PubMed ID: 10868688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia.
    Pakakasama S; Mukda E; Sasanakul W; Kadegasem P; Udomsubpayakul U; Thithapandha A; Hongeng S
    Am J Hematol; 2005 Jul; 79(3):202-5. PubMed ID: 15981231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
    Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
    Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia].
    Gra OA; Glotov AS; Kozhekbaeva Zhm; Makarova OV; Nasedkina TV
    Mol Biol (Mosk); 2008; 42(2):214-25. PubMed ID: 18610829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia.
    Tumer TB; Yilmaz D; Tanrikut C; Sahin G; Ulusoy G; Arinç E
    Leuk Res; 2010 Oct; 34(10):1275-81. PubMed ID: 20394984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome.
    Krajinovic M; Labuda D; Sinnett D
    Rev Environ Health; 2001; 16(4):263-79. PubMed ID: 12041882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.
    Batar B; Güven M; Bariş S; Celkan T; Yildiz I
    Leuk Res; 2009 Jun; 33(6):759-63. PubMed ID: 19101034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CYP1A1, GSTP1 and XRCC1 genes polymorphisms on toxicity and response to chemotherapy in childhood acute lymphoblastic leukemia.
    Abo-Bakr A; Mossallam G; El Azhary N; Hafez H; Badawy R
    J Egypt Natl Canc Inst; 2017 Sep; 29(3):127-133. PubMed ID: 28844589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
    Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
    Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.